Minocycline attenuates cholinergic dysfunction and neuro-inflammation-mediated cognitive impairment in scopolamine-induced Alzheimer's rat model.
Sabiheh AmirahmadiFaezeh Dabouri FarimaniMahsan AkbarianFarshad MirzaviMohammad Hossein Eshaghi GhalibafArezoo RajabianMahmoud HosseiniPublished in: Inflammopharmacology (2022)
Taken together, the data indicate that treatment with minocycline improved memory dysfunction mediated possibly through restoring AChE and ChRM1 levels, oxidant/antioxidant balance, as well as inhibiting inflammatory responses.